{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:42:35Z","timestamp":1765827755737,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10096-019-03500-7","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T17:17:32Z","timestamp":1549473452000},"page":"903-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus"],"prefix":"10.1007","volume":"38","author":[{"given":"Roc\u00edo","family":"Falc\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Oltra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseo","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-4110","authenticated-orcid":false,"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"3500_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","volume":"46","author":"A Soriano","year":"2008","unstructured":"Soriano A, Marco F, Mart\u00ednez JA, Pisos E, Almela M, Dimova VP et al (2008) Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46:193\u2013200","journal-title":"Clin Infect Dis"},{"key":"3500_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1086\/603589","volume":"49","author":"F Pea","year":"2009","unstructured":"Pea F, Viale P (2009) Is the minimum inhibitory concentration of vancomycin an infallible predictor of the clinical outcome of Staphylococcus aureus bacteremia treated with vancomycin? Clin Infect Dis 49:642\u2013643","journal-title":"Clin Infect Dis"},{"key":"3500_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/infdis\/jir270","volume":"204","author":"NE Holmes","year":"2011","unstructured":"Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV et al (2011) Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 204:340\u2013347","journal-title":"J Infect Dis"},{"key":"3500_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3201\/eid\/1706.101037","volume":"17","author":"JM Aguado","year":"2011","unstructured":"Aguado JM, San-Juan R, Lalueza A, Sanz F, Rodr\u00edguez-Otero J, G\u00f3mez-Gonzalez C et al (2011) High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerg Infect Dis 17:1099\u20131102","journal-title":"Emerg Infect Dis"},{"key":"3500_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/infdis\/jir275","volume":"204","author":"TL Holland","year":"2011","unstructured":"Holland TL, Fowler VG Jr (2011) Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet? J Infect Dis 204:329\u2013331","journal-title":"J Infect Dis"},{"key":"3500_CR6","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/infdis\/jir870","volume":"205","author":"JM Aguado","year":"2012","unstructured":"Aguado JM, San-Juan R, Fern\u00e1ndez-Ruiz M, Chaves F (2012) Role of high vancomycin minimum inhibitory concentration in the outcome of methicillin-susceptible Staphylococcus aureus bacteremia. J Infect Dis 205:1024\u20131025","journal-title":"J Infect Dis"},{"key":"3500_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/infdis\/jir848","volume":"205","author":"IM Gould","year":"2012","unstructured":"Gould IM (2012) Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection. J Infect Dis 205:864\u2013865","journal-title":"J Infect Dis"},{"key":"3500_CR8","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/cid\/ciu183","volume":"58","author":"C Cervera","year":"2014","unstructured":"Cervera C, Casta\u00f1eda X, Garc\u00eda de la Mar\u00eda C, del Rio A, Moreno A, Soy D et al (2014) Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis. Clin Infect Dis 58:1668\u20131675","journal-title":"Clin Infect Dis"},{"key":"3500_CR9","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.ijid.2012.08.005","volume":"17","author":"JT Jacob","year":"2013","unstructured":"Jacob JT, Diaz Granados CA (2013) High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis 17:e93\u2013e100","journal-title":"Int J Infect Dis"},{"key":"3500_CR10","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/jama.2014.6364","volume":"312","author":"AC Kalil","year":"2014","unstructured":"Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME (2014) Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA 312:1552\u20131564","journal-title":"JAMA"},{"key":"3500_CR11","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/jac\/dks128","volume":"67","author":"L Rojas","year":"2012","unstructured":"Rojas L, Bunsow E, Mu\u00f1oz P, Cercenado E, Rodr\u00edguez-Cr\u00e9ixems M, Bouza E (2012) Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients. J Antimicrob Chemother 67:1760\u20131768","journal-title":"J Antimicrob Chemother"},{"key":"3500_CR12","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/jac\/dkv133","volume":"70","author":"LE L\u00f3pez-Cort\u00e9s","year":"2015","unstructured":"L\u00f3pez-Cort\u00e9s LE, Velasco C, Retamar P, del Toro MD, G\u00e1lvez-Acebal J, de Cueto M et al (2015) Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia? J Antimicrob Chemother 70:2652\u20132660","journal-title":"J Antimicrob Chemother"},{"key":"3500_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/jac\/dkt340","volume":"69","author":"SY Chen","year":"2014","unstructured":"Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC et al (2014) Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 69:211\u2013218","journal-title":"J Antimicrob Chemother"},{"key":"3500_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ijantimicag.2015.07.013","volume":"46","author":"H Shoji","year":"2015","unstructured":"Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K et al (2015) More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia. Int J Antimicrob Agents 46:532\u2013537","journal-title":"Int J Antimicrob Agents"},{"key":"3500_CR15","doi-asserted-by":"publisher","first-page":"e02512","DOI":"10.1128\/AAC.02512-17","volume":"62","author":"S Adani","year":"2018","unstructured":"Adani S, Bhowmick T, Weinstein MP, Narayanan N (2018) Impact of vancomycin MIC on clinical outcomes of patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin at an institution with suppressed MIC reporting. Antimicrob Agents Chemother 62:e02512\u2013e02517","journal-title":"Antimicrob Agents Chemother"},{"key":"3500_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ijantimicag.2017.12.028","volume":"51","author":"K Bouiller","year":"2018","unstructured":"Bouiller K, Laborde C, Aho SL, Hocquet D, Pechinot A, Le Moing V et al (2018) No effect of vancomycin MIC\u2009\u2265\u20091.5\u2009mg\/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia. Int J Antimicrob Agents 51:721\u2013726","journal-title":"Int J Antimicrob Agents"},{"key":"3500_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cmi.2017.12.002","volume":"24","author":"N Fern\u00e1ndez-Hidalgo","year":"2018","unstructured":"Fern\u00e1ndez-Hidalgo N, Ribera A, Larrosa MN, Viedma E, Orig\u00fcen J, de Alarc\u00f3n A et al (2018) Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study. Clin Microbiol Infect 24:985\u2013991","journal-title":"Clin Microbiol Infect"},{"key":"3500_CR18","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/jac\/dkx096","volume":"72","author":"R San-Juan","year":"2017","unstructured":"San-Juan R, Fern\u00e1ndez-Ruiz M, Gasch O, Camoez M, L\u00f3pez-Medrano F, Dom\u00ednguez M\u00c1 et al (2017) High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 72:2102\u20132109","journal-title":"J Antimicrob Chemother"},{"key":"3500_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/1469-0691.12108","volume":"19","author":"O Gasch","year":"2013","unstructured":"Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B et al (2013) Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. Clin Microbiol Infect 19:1049\u20131057","journal-title":"Clin Microbiol Infect"},{"key":"3500_CR20","doi-asserted-by":"publisher","first-page":"e00316","DOI":"10.1128\/AAC.00316-17","volume":"61","author":"SB Sullivan","year":"2017","unstructured":"Sullivan SB, Austin ED, Stump S, Mathema B, Whittier S, Lowy FD et al (2017) Reduced vancomycin susceptibility of methicillin-susceptible Staphylococcus aureus has no significant impact on mortality but results in an increase in complicated infection. Antimicrob Agents Chemother 61:e00316\u2013e00317","journal-title":"Antimicrob Agents Chemother"},{"key":"3500_CR21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/cid\/civ583","volume":"61","author":"R Falc\u00f3n","year":"2015","unstructured":"Falc\u00f3n R, Madrid S, Tormo N, Casa\u00f1 C, Albert E, Gimeno C et al (2015) Intra- and interinstitutional evaluation of an Etest for vancomycin minimum inhibitory concentration measurement in Staphylococcus aureus blood isolates. Clin Infect Dis 61:1490\u20131492","journal-title":"Clin Infect Dis"},{"key":"3500_CR22","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s10096-017-3067-8","volume":"36","author":"R Falc\u00f3n","year":"2017","unstructured":"Falc\u00f3n R, Mateo EM, Talaya A, Gim\u00e9nez E, Vinuesa V, Clari M\u00c1 et al (2017) Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a \u201cquasi-continuum\u201d gradient of antibiotic concentrations. Eur J Clin Microbiol Infect Dis 36:2355\u20132360","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3500_CR23","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1128\/AAC.44.9.2276-2285.2000","volume":"44","author":"L Cui","year":"2000","unstructured":"Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K (2000) Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 44:2276\u20132285","journal-title":"Antimicrob Agents Chemother"},{"key":"3500_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","volume":"41","author":"L Cui","year":"2003","unstructured":"Cui L, Ma X, Sato K, Tenover FC, Mamizuka EM, Gemmell CG et al (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5\u201314","journal-title":"J Clin Microbiol"},{"key":"3500_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijantimicag.2016.01.014","volume":"47","author":"R Falc\u00f3n","year":"2016","unstructured":"Falc\u00f3n R, Mart\u00ednez A, Albert E, Madrid S, Oltra R, Gim\u00e9nez E et al (2016) High vancomycin MICs within the susceptible range in Staphylococcus aureus bacteraemia isolates are associated with increased cell wall thickness and reduced intracellular killing by human phagocytes. Int J Antimicrob Agents 47:343\u2013350","journal-title":"Int J Antimicrob Agents"},{"key":"3500_CR26","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/JCM.00905-08","volume":"46","author":"T Lalani","year":"2008","unstructured":"Lalani T, Federspiel JJ, Boucher HW, Rude TH, Bae IG, Rybak MJ et al (2008) Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol 46:2890\u20132896","journal-title":"J Clin Microbiol"},{"key":"3500_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jac\/dkt337","volume":"69","author":"E Viedma","year":"2014","unstructured":"Viedma E, Sanz F, Orellana MA, San Juan R, Aguado JM, Otero JR et al (2014) Relationship between agr dysfunction and reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus causing bacteraemia. J Antimicrob Chemother 69:51\u201358","journal-title":"J Antimicrob Chemother"},{"key":"3500_CR28","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1128\/JCM.01320-14","volume":"52","author":"NE Holmes","year":"2014","unstructured":"Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV et al (2014) Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates. J Clin Microbiol 52:3384\u20133393","journal-title":"J Clin Microbiol"},{"key":"3500_CR29","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s10096-017-2989-5","volume":"36","author":"R San-Juan","year":"2017","unstructured":"San-Juan R, P\u00e9rez-Montarelo D, Viedma E, Lalueza A, Fort\u00fan J, Loza E et al (2017) Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study. Eur J Clin Microbiol Infect Dis 36:1757\u20131765","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3500_CR30","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1128\/JCM.02215-10","volume":"49","author":"MC Kruzel","year":"2011","unstructured":"Kruzel MC, Lewis CT, Welsh KJ, Lewis EM, Dundas NE, Mohr JF et al (2011) Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 49:2272\u20132273","journal-title":"J Clin Microbiol"},{"key":"3500_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijantimicag.2010.12.004","volume":"37","author":"B Mu\u00f1oz-Cobo","year":"2011","unstructured":"Mu\u00f1oz-Cobo B, Sancho-Tello S, Costa E, Bravo D, Torregrosa I, de Lomas JG et al (2011) Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix\u2122 system, the clinical and laboratory standards institute broth microdilution method and the standard Etest. Int J Antimicrob Agents 37:278\u2013279","journal-title":"Int J Antimicrob Agents"},{"key":"3500_CR32","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1128\/JCM.01571-14","volume":"52","author":"CL Charlton","year":"2014","unstructured":"Charlton CL, Hindler JA, Turnidge J, Humphries RM (2014) Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage. J Clin Microbiol 52:3898\u20133905","journal-title":"J Clin Microbiol"},{"key":"3500_CR33","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1128\/AAC.00658-16","volume":"60","author":"SM Baxi","year":"2016","unstructured":"Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E et al (2016) Vancomycin MIC does not predict 90-day mortality, readmission, or recurrence in a prospective cohort of adults with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 60:5276\u20135284","journal-title":"Antimicrob Agents Chemother"},{"key":"3500_CR34","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1086\/520088","volume":"196","author":"VG Fowler Jr","year":"2007","unstructured":"Fowler VG Jr, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, Archer GL et al (2007) Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 196:738\u2013747","journal-title":"J Infect Dis"},{"key":"3500_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1086\/595738","volume":"199","author":"YQ Xiong","year":"2009","unstructured":"Xiong YQ, Fowler VG, Yeaman MR, Perdreau-Remington F, Kreiswirth BN, Bayer AS (2009) Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. J Infect Dis 199:201\u2013208","journal-title":"J Infect Dis"},{"key":"3500_CR36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/infdis\/jir389","volume":"204","author":"JJ Nienaber","year":"2011","unstructured":"Nienaber JJ, Sharma Kuinkel BK, Clarke-Pearson M, Lamlertthon S, Park L, Rude TH et al (2011) Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J Infect Dis 204:704\u2013713","journal-title":"J Infect Dis"},{"key":"3500_CR37","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1128\/JCM.00651-13","volume":"51","author":"C Nethercott","year":"2013","unstructured":"Nethercott C, Mabbett AN, Totsika M, Peters P, Ortiz JC, Nimmo GR et al (2013) Molecular characterization of endocarditis-associated Staphylococcus aureus. J Clin Microbiol 51:2131\u20132138","journal-title":"J Clin Microbiol"},{"key":"3500_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.meegid.2015.08.029","volume":"36","author":"C Bouchiat","year":"2015","unstructured":"Bouchiat C, Moreau K, Devillard S, Rasigade JP, Mosnier A, Geissmann T et al (2015) Staphylococcus aureus infective endocarditis versus bacteremia strains: subtle genetic differences at stake. Infect Genet Evol 36:524\u2013530","journal-title":"Infect Genet Evol"},{"key":"3500_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1155\/2014\/853482","volume":"25","author":"H Wong","year":"2014","unstructured":"Wong H, Watt C, Elsayed S, John M, Johnson G, Katz K et al (2014) Characterization of methicillin-resistant Staphylococcus aureus isolates from patients with persistent or recurrent bacteremia. Can J Infect Dis Med Microbiol 25:83\u201386","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"3500_CR40","doi-asserted-by":"publisher","unstructured":"Lilje B, Rasmussen RV, Dahl A, Stegger M, Skov RL, Fowler VG, et al. (2017) Whole-genome sequencing of bloodstream Staphylococcus aureus isolates does not distinguish bacteraemia from endocarditis. Microb Genom. \n                    https:\/\/doi.org\/10.1099\/mgen.0.000138","DOI":"10.1099\/mgen.0.000138"},{"key":"3500_CR41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1128\/CMR.00104-12","volume":"26","author":"AR Spaulding","year":"2013","unstructured":"Spaulding AR, Salgado-Pabon W, Kohler PL, Horswill AR, Leung DY, Schlievert PM (2013) Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 26:422\u2013447","journal-title":"Clin Microbiol Rev"},{"key":"3500_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.immunol.17.1.435","volume":"17","author":"H Li","year":"1999","unstructured":"Li H, Llera A, Malchiodi EL, Mariuzza RA (1999) The structural basis of T cell activation by superantigens. Annu Rev Immunol 17:435\u2013466","journal-title":"Annu Rev Immunol"},{"key":"3500_CR43","doi-asserted-by":"publisher","unstructured":"Salgado-Pab\u00f3n W, Breshears L, Spaulding AR, Merriman JA, Stach CS, Horswill AR et al. (2013) Superantigens are critical for Staphylococcus aureus infective endocarditis, sepsis, and acute kidney injury. MBio. \n                    https:\/\/doi.org\/10.1128\/mBio.00494-13","DOI":"10.1128\/mBio.00494-13"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03500-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03500-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03500-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:19:09Z","timestamp":1567073949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03500-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3500"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03500-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"24 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None to declare","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declarations"}}]}}